Arbutus Biopharma Corporation (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.51
+2.85%
Mkt Cap $841.51M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
Implied Upside
+88.7%
Consensus $8.50 vs current $4.51
NASDAQ·Healthcare·Biotechnology
$4.51
+2.85%
Mkt Cap $841.51M
No recent rating data.
Price Target (1 analysts)
$8.50
Range $8.50 – $8.50
+88.7%
Consensus $8.50 vs current $4.51